0000899243-22-016635.txt : 20220504 0000899243-22-016635.hdr.sgml : 20220504 20220504170722 ACCESSION NUMBER: 0000899243-22-016635 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WAGNER CHARLES F JR CENTRAL INDEX KEY: 0001223348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22892502 MAIL ADDRESS: STREET 1: C/O MILLIPORE CORP CITY: BILLERICA STATE: MA ZIP: 01820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001223348 WAGNER CHARLES F JR C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & Chief Financial Officer Common Stock 2022-05-02 4 S 0 20 254.87 D 43053 D Common Stock 2022-05-02 4 S 0 100 257.18 D 42953 D Common Stock 2022-05-02 4 S 0 60 258.21 D 42893 D Common Stock 2022-05-02 4 S 0 80 259.45 D 42813 D Common Stock 2022-05-02 4 S 0 48 261.15 D 42765 D Common Stock 2022-05-02 4 S 0 32 262.06 D 42733 D Common Stock 2022-05-02 4 S 0 3 264.37 D 42730 D Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1. Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47). Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61). Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90). Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63). Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23). /s/ Sabrina Yohai, Attorney-in-Fact 2022-05-04